Ref ID: 19185
Author:
M. Drogari-Apiranthitou*, I. Panayiotides, I. Galani, S. Pappa, D. Katsala, S. Tsiodras, G.L. Petrikkos
Author address:
Athens, GR
Full conference title:
23rd European Congress of Clinical Microbiology and
Infectious Diseases
Date: 27 April 2014
Abstract:
Objectives. The epidemiology of invasive and emerging fungal infections in our area is unknown. We sought to retrospectively identify cases of aspergillosis or mucormycosis in our institution, using a more specific, molecular method in addition to routine culture and the “œgold standard” histopathology.
Methods. Pathology records of patients treated in our hospital during the years 2005-2012 and having undergone tissue biopsies, were reviewed. Cases with histopathology compatible with invasive fungal infection were retrieved and cuts from formalin-fixed and paraffin-embedded tissues were prepared. Demographic, clinical and microbiological data were analysed. After deparaffinization and DNA extraction using a Qiagen tissue kit, a semi-nested PCR for the detection of Mucorales and Aspergillus species as described by Bialek et al. 2005, was applied.
Results. In total, 22 cases with biopsies positive for fungal elements were retrieved. Aspergillus species were identified in 6 patients. Seven patients had a fungus not identifiable by the used molecular method but grown in culture (1 Bipolaris spp., 1 Scedosporium proliferatum, 1 Scedosporium apiospermum, 1 Fusarium spp., 2 Candida spp.) and 1 was not cultured. Nine cases were due to Mucorales, only 4 of which had a positive culture (Rhizopus spp.). In total, 31 samples from 15 patients with either mucormycosis or aspergillosis were examined. Of these, 8 were false negative, nevertheless at least one sample of each patient was positive. In one case a double infection, with Aspergillus and Mucorales was identified, missed by histopathology, whereas another case with presumed double infection, was not confirmed molecularly.
Conclusion. Mucormycosis cases exceeded aspergillosis in our setting. The nested PCR method performed well, with a sensitivity of 74% and 100% specificity. This method constitutes an additional powerful tool for prompt and accurate diagnosis of these infections. This is particularly important for mucormycosis which is a rapidly progressing and devastating emerging infection. Utilization of more than 2 samples per patient may increase sensitivity.
Abstract Number: P1100
Conference Year: 2013
Link to conference website: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=166017&XNSPRACHE_ID=2&XNKONGRESS_ID=180&XNMASK
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a